Refractive Surgery News

Two FDA actions topped ophthalmology news in November, with an approval for the MiSight contact lens and an orphan drug designation for ProQR’s retinitis pigmentosa treatment.

Johnson & Johnson Vision is launching the Tecnis toric II one-piece IOL, which has been approved by the FDA, according to a press release.

NEW YORK — At OSN New York 2019, John P. Berdahl, MD, discusses his early visual results in patients implanted with the Light Adjustable Lens from RxSight.

Patients who underwent femtosecond lenticule extraction for the treatment of myopia and myopic astigmatism had stable results 10 years after the procedure.

EyeGate Pharmaceuticals’ Ocular Bandage Gel eye drop improved corneal re-epithelialization better than a bandage contact lens in a pivotal PRK study, thus achieving the study’s primary endpoint, according to a press release.

NEW YORK — At OSN New York 2019, Elizabeth Yeu, MD, discusses the reasons behind and strategies for dealing with toric IOL visual acuity surprises following implantation.

NEW YORK — Epi-Bowman keratectomy removes a patient’s epithelium in layers as atraumatically as possible during surface ablation and can reduce irregular ablation rates when compared with PRK, according to a speaker here.

NEW YORK — The integration of SMILE into clinical practice takes patience and the willingness to experience a learning curve, a speaker said here.

NEW YORK — Since its commercial rollout in July, the Light Adjustable Lens has been implanted in 18 sites across the country, offering surgeons simplified preoperative messaging and decision-making and delivering better vision for patients, according to a speaker here.

In October, the American Academy of Ophthalmology held its annual meeting in San Francisco.